Reply: KRAS Status Analysis and Anti-Egfr Therapies: Is Comprehensiveness a Biologist's Fancy or a Clinical Necessity?

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC